Noxopharm Limited (ASX: NOX)


Company Profile: Noxopharm Limited (ASX: NOX) is a clinical-stage Australian drug development company which is focused on creating drugs to treat cancer in an innovative way. The company is headed by Dr. Graham Kelly who is the Chief Executive Officer (CEO) and Managing Director (MD) of the company. The company was listed on ASX in 2016 and the headquarter of the company is located in Pacific Highway Gordon New South Wales, Australia.